Jitendra Mohan - Nov 25, 2024 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Signature
/s/ Philip Mazzara, Attorney-in-Fact
Stock symbol
ALAB
Transactions as of
Nov 25, 2024
Transactions value $
-$19,091,428
Form type
4
Date filed
11/27/2024, 05:26 PM
Previous filing
Nov 25, 2024
Next filing
Dec 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALAB Common Stock Sale -$3.18M -28.9K -0.65% $110.12 4.44M Nov 25, 2024 By Living Trust F1, F2, F3
transaction ALAB Common Stock Sale -$3.18M -28.9K -3.29% $110.12 850K Nov 25, 2024 By 2021 Trust 1 F1, F2, F4
transaction ALAB Common Stock Sale -$3.18M -28.9K -3.29% $110.12 850K Nov 25, 2024 By 2021 Trust 2 F1, F2, F5
transaction ALAB Common Stock Sale -$3.18M -28.9K -4.59% $110.12 600K Nov 25, 2024 By 2022 Trust 1 F1, F2, F6
transaction ALAB Common Stock Sale -$3.18M -28.9K -4.59% $110.12 600K Nov 25, 2024 By 2022 Trust 2 F1, F2, F7
transaction ALAB Common Stock Sale -$3.18M -28.9K -3.29% $110.12 850K Nov 25, 2024 By Trust F1, F2, F8
holding ALAB Common Stock 2.7M Nov 25, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024.
F2 The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F5 These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F6 These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F7 These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F8 These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.